LINQ II Insertable Cardiac Monitor vs Withings ECG App

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by Withings

AI Verdict

Tool A, the Medtronic LINQ II, is an advanced insertable cardiac monitor providing long-term, continuous, diagnostic-grade heart rhythm monitoring for clinical use. In contrast, Tool B, the Withings ECG App, is a consumer-grade software for a wearable device, offering on-demand single-lead ECGs for personal health management and early detection of conditions like AFib. While both utilize AI for cardiac insights and detect arrhythmias, their fundamental deployment, invasiveness, and target users differentiate them significantly.

Choose LINQ II Insertable Cardiac Monitor if…

Choose the Medtronic LINQ II if your patient requires long-term, continuous, and highly accurate monitoring for infrequent or asymptomatic arrhythmias that may not be captured by external devices. This insertable cardiac monitor is ideal for comprehensive diagnostic evaluation over several years, offering AI-powered detection and remote management by clinicians.

View LINQ II Insertable Cardiac Monitor →

Choose Withings ECG App if…

Choose the Withings ECG App if you are an individual seeking an accessible, on-demand solution for personal heart rhythm monitoring and early detection of conditions like AFib. This tool empowers users to record single-lead ECGs conveniently at home using a compatible smartwatch and easily share reports with their healthcare provider for review.

View Withings ECG App →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature LINQ II Insertable Cardiac Monitor Withings ECG App
Pricing Unknown Subscription-based for withings+
Deployment Subcutaneous implant with remote monitoring via mobile app or home communicator. Mobile app, Web app
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Withings ECG App

The Withings ECG App offers superior everyday usability due to its over-the-counter nature and integration with a user-friendly smartwatch, allowing for easy, on-demand ECG recordings. A study indicated that smartwatches are perceived as easier to wear and less intrusive than traditional Holter monitors. In contrast, the LINQ II requires an invasive surgical procedure for insertion, making its initial accessibility and setup more involved.

Clinical Value

LINQ II Insertable Cardiac Monitor

The Medtronic LINQ II provides significantly higher clinical value through its long-term (up to 4.5 years), continuous heart rhythm monitoring, advanced AccuRhythmu2122 AI algorithms for enhanced accuracy and false alert reduction, and remote programming capabilities. It is designed for comprehensive diagnosis of various arrhythmias in patients at increased risk, offering a more robust diagnostic and management tool than the Withings ECG App's on-demand, single-lead ECG for specific rhythm detections.

Pricing & Value

Withings ECG App

The Withings ECG App offers transparent and consumer-friendly pricing, with the core app functionality included with a compatible Withings smartwatch and an optional premium subscription for enhanced features at a clear monthly or annual cost. The Medtronic LINQ II, as an implantable medical device, has enterprise-level pricing that is negotiated with healthcare systems and not publicly disclosed, implying a significantly higher and less transparent cost for individual patients or smaller practices.

Enterprise Readiness

LINQ II Insertable Cardiac Monitor

The Medtronic LINQ II is explicitly designed for integration into healthcare systems, targeting solo to large health systems with a hybrid deployment model and a large existing patient base. Medtronic provides extensive professional support and infrastructure for clinical workflows. While the Withings ECG App is FDA-cleared and HIPAA compliant, its primary design and market are consumer-facing, making it less suited for direct enterprise-level healthcare integration.

Innovation

LINQ II Insertable Cardiac Monitor

The Medtronic LINQ II demonstrates significant innovation in implantable cardiac monitoring with its advanced AccuRhythmu2122 AI algorithms that enhance diagnostic accuracy and reduce false alerts, remote programming capabilities, and extended battery life for continuous, long-term monitoring. While the Withings ECG App innovates by bringing medical-grade ECG to a consumer wearable, Tool A's advancements in specialized medical technology for complex diagnostics are more profound.

Support & Docs

LINQ II Insertable Cardiac Monitor

Medtronic, as a leading medical device company, provides comprehensive professional-grade support and extensive documentation tailored for healthcare professionals and systems, including technical manuals, clinician education via Medtronic Academy, and 24-hour support lines. Withings offers consumer-focused support through user guides and FAQs, which, while adequate for its target audience, does not match the depth and breadth of professional support required for an implantable medical device.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature LINQ II Insertable Cardiac Monitor Withings ECG App
Name LINQ II Insertable Cardiac Monitor Withings ECG App
Company Medtronic Withings
Description The Medtronic LINQ II is an advanced, AI-powered insertable cardiac monitor providing long-term, continuous heart rhythm monitoring with remote programming and enhanced accuracy for diagnosing arrhythmias. The Withings ECG App, an FDA-cleared software for ScanWatch, enables users to record single-channel ECGs, detect atrial fibrillation (AFib), sinus rhythm, and high heart rate, and share data with healthcare professionals.
Key Features AccuRhythmu2122 AI algorithms for enhanced accuracy, Remote programming capability, Up to 4.5 years of continuous monitoring, MRI compatibility (1.5 and 3.0T), MyCareLink Heartu2122 mobile app for data transmission, MyCareLink Relayu2122 home communicator option, Innovative PVC detection algorithm, Pediatric indication (ages 2+) Single-lead ECG recording (Lead I equivalent), Atrial Fibrillation (AFib) detection, Sinus rhythm detection, High heart rate detection (100-150 bpm), Companion mobile app for data visualization and history, Ability to share ECG reports as PDFs with physicians, Over-the-counter (OTC) use, Integration with Withings ScanWatch devices
Target Size Solo to large health systems Not specified

Videos

Demos, reviews, and walkthroughs featuring LINQ II Insertable Cardiac Monitor and Withings ECG App.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Medtronic LINQ II is an insertable cardiac monitor that provides long-term, continuous heart rhythm monitoring for up to 4.5 years. In contrast, the Withings ECG App, used with a compatible Withings smartwatch, enables users to record single-channel ECGs on demand or for specific events.
The Medtronic LINQ II is designed for diagnosing arrhythmias and includes an innovative PVC detection algorithm, utilizing AccuRhythmu2122 AI algorithms for enhanced accuracy. The Withings ECG App can detect atrial fibrillation (AFib), sinus rhythm, and high heart rate (100-150 bpm).
For the Medtronic LINQ II, data is transmitted via the MyCareLink Heartu2122 mobile app or the MyCareLink Relayu2122 home communicator to the CareLinku2122 network, which doctors can access. The Withings ECG App allows users to visualize data and history in its companion mobile app and share ECG reports as PDFs with physicians.
The Medtronic LINQ II is indicated for adult and pediatric patients (ages 2+) who have abnormal heart rhythms or transient symptoms requiring long-term, continuous monitoring. The Withings ECG App is intended for over-the-counter (OTC) use by individuals 22 years of age or older for personal health monitoring and detecting AFib, sinus rhythm, and high heart rate.
The Medtronic LINQ II offers remote programming, MRI compatibility (1.5 and 3.0T), and up to 4.5 years of continuous monitoring. The Withings ECG App provides single-lead ECG recording (Lead I equivalent) for over-the-counter use, integrates with Withings ScanWatch devices, and offers optional AI-powered insights and cardiologist reviews through its premium subscription.
AI Tool Finder
AI-powered search. Results may not be comprehensive.